M Kurtz Biography and Net Worth

CEO of RxSight

Dr. Kurtz has served as our President and Chief Executive Officer, as well as on our board since 2016. Prior to joining RxSight, he co-founded and served as President and Chief Executive Officer of LenSx Lasers, Inc. He became General Manager of Alcon LenSx, Inc after the company was acquired by Alcon Inc. (NYSE:ALC) in 2010. Dr. Kurtz previously co-founded IntraLase Corp. (NASDAQ:ILSE) serving as its initial President & CEO and then in other senior leadership positions. IntraLase became a publicly held NASDAQ-listed company in 2004 and was acquired by Advanced Medical Optics, Inc. (NYSE:AMO) in 2007. Dr. Kurtz has served on the faculty of both the University of California, Irvine, and the University of Michigan. He earned his B.A. in Biochemistry from Harvard College and his M.D. from the University of California, San Diego.

What is M Md Kurtz's net worth?: The estimated net worth of M Md Kurtz is at least $381.84 thousand as of September 2nd, 2026. Kurtz owns 71,775 shares of RxSight stock worth more than $381,843 as of September 17th. This net worth estimate does not reflect any other assets that Kurtz may own. Learn More about M Md Kurtz's net worth.
How do I contact M Md Kurtz?: The corporate mailing address for Kurtz and other RxSight executives is 100 Columbia Street, Suite 120, Aliso Viejo, CA, 92656. RxSight can also be reached via phone at 949-521-7830 and via email at [email protected]. Learn More on M Md Kurtz's contact information.
Has M Md Kurtz been buying or selling shares of RxSight?: During the last ninety days, M Md Kurtz has sold $35,496.00 in shares of RxSight stock. Most recently, M Md Kurtz sold 5,100 shares of the business's stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $6.96, for a transaction totalling $35,496.00. Following the completion of the sale, the insider now directly owns 71,775 shares of the company's stock, valued at $499,554. Learn More on M Md Kurtz's trading history.
Who are RxSight's active insiders?: RxSight's insider roster includes Julie Andrews (Director), Juliet Bakker (Director), Jesse Corley (Director), Tamara Fountain (Director), Ilya Goldshleger (Insider), Ilya Goldshleger (Insider), M Kurtz (CEO), William Link (Director), Shweta Maniar (Director), Shelley Thunen (CFO), Robert Warner (Director), and Eric Weinberg (Insider). Learn More on RxSight's active insiders.
Are insiders buying or selling shares of RxSight?: In the last year, insiders at the sold shares 4 times. They sold a total of 16,947 shares worth more than $117,951.12. The most recent insider tranaction occured on September, 2nd when insider M Md Kurtz sold 5,100 shares worth more than $35,496.00. Insiders at RxSight own 10.1% of the company. Learn More about insider trades at RxSight.
Information on this page was last updated on 9/2/2026.

M Md Kurtz Insider Trading History at RxSight

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/2/2026	Sell	5,100	$6.96	$35,496.00	71,775
5/3/2024	Sell	40,000	$60.15	$2,406,000.00	764,610
1/8/2024	Sell	62,500	$44.25	$2,765,625.00	804,610
12/27/2023	Sell	22,500	$41.09	$924,525.00	867,110
12/14/2023	Sell	40,000	$39.70	$1,588,000.00	889,610

M Md Kurtz Buying and Selling Activity at RxSight

RxSight Company Overview

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Today's Range

Now: $5.32

$5.17

$5.58

50 Day Range

MA: $6.11

$4.92

$7.33

2 Week Range

Now: $5.32

$4.48

$13.22

Volume

1,011,843 shs

Average Volume

770,798 shs

Market Capitalization

$221.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.16